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Abstract
Background: HIV protease inhibitors (PI) are core components of Highly Active Antiretroviral Therapy (HAART), the most
effective treatment for HIV infection currently available. However, HIV PIs have now been linked to lipodystrophy and
dyslipidemia, which are major risk factors for cardiovascular disease and metabolic syndrome. Our previous studies have
shown that HIV PIs activate endoplasmic reticulum (ER) stress and disrupt lipid metabolism in hepatocytes and
macrophages. Yet, little is known on how HIV PIs disrupt lipid metabolism in adipocytes, a major cell type involved in the
pathogenesis of metabolic syndrome.
Methodology and Principal Findings: Cultured and primary mouse adipocytes and human adipocytes were used to
examine the effect of frequently used HIV PIs in the clinic, lopinavir/ritonavir, on adipocyte differentiation and further
identify the underlying molecular mechanism of HIV PI-induced dysregulation of lipid metabolism in adipocytes. The results
indicated that lopinavir alone or in combination with ritonavir, significantly activated the ER stress response, inhibited cell
differentiation, and induced cell apoptosis in adipocytes. In addition, HIV PI-induced ER stress was closely linked to
inhibition of autophagy activity. We also identified through the use of primary adipocytes of CHOP2/2 mice that CHOP, the
major transcriptional factor of the ER stress signaling pathway, is involved in lopinavir/ritonavir-induced inhibition of cell
differentiation in adipocytes. In addition, lopinavir/ritonavir-induced ER stress appears to be associated with inhibition of
autophagy activity in adipocytes.
Conclusion and Significance: Activation of ER stress and impairment of autophagy activity are involved in HIV PI-induced
dysregulation of lipid metabolism in adipocytes. The key components of ER stress and autophagy signaling pathways are
potential therapeutic targets for HIV PI-induced metabolic side effects in HIV patients.
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Introduction
The development of HIV protease inhibitors (PIs) was one of
the most significant advances of the past two decades for
controlling HIV infection. Formulation of Highly Active Anti-
retroviral Therapy (HAART) with the inclusion of HIV PIs in
patient treatment has had a profound impact on the clinical
history of HIV. However, HAART has been linked to cardiovas-
cular complications and metabolic syndrome in HIV-1 patients. It
has been well-documented that HIV PIs specifically induce many
of these deleterious effects including early induction of insulin
resistance, dysregulation of lipid metabolism, and inflammation,
all of which are cornerstones of cardiovascular and metabolic
diseases [1,2].
During the last decade, an extensive effort has been put forth to
study the mechanism underlying HIV PI-induced side effects.
Both in vitro and in vivo animal studies from our laboratory and
others’ have linked the activation of endoplasmic reticulum (ER)
stress to HIV PI-induced cell apoptosis, dyslipidemia, inflamma-
tion, and insulin resistance in several metabolically important cell
types including hepatocytes, macrophages, and adipocytes [3–7].
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The contribution of adipocytes to the pathogenesis of cardiovas-
cular and metabolic diseases is becoming widely appreciated.
Adipocytes are not only storage units for triglycerides, but also
influence systemic lipid homeostasis through the production and
release of adipocyte-specific and adipocyte-enriched hormonal
factors, inflammatory mediators and adipokines. Disruption of
cellular homeostasis of adipocytes can be central in the in-
flammatory state, insulin resistance, dyslipidemia, and altered
body morphology [8–14]. HIV PIs have surprisingly similar effects
in HIV-infected patients [15–19]. Several studies have reported
that HIV PIs inhibit adipocyte differentiation, alter the expression
of adipocytokines, and induce insulin resistance [20–24].
Autophagy is an intracellular protein degradation system
required for normal turnover of cellular components and for the
starvation response and plays an important physiological role in
eukaryotic cells [25]. It has been recently discovered that
autophagy activation is closely linked to ER stress and the
unfolded protein response (UPR) pathways [26]. Autophagy is not
only a critical regulator of hepatic lipid metabolism, but also plays
an important role in regulation of adipose lipid storage and
adipocyte differentiation [25,27,28]. However, little is known
about how ER stress and autophagy interact in HIV PI-induced
dysregulation of lipid metabolism in adipocytes.
In this study, we examined the effect of current clinically
relevant HIV PIs on ER stress and autophagy activation both in
cultured mouse and human adipocytes and primary mouse
adipocytes, and further identified the potential link between these
two important cellular pathways in HIV PI-induced dysfunction of
adipocytes.
Materials and Methods
Materials: Antibodies against C/EBP homologous protein
(CHOP), activating transcription factor-4 (ATF-4), X-box-binding
protein-1 (XBP-1), lamin B, ATG5, ATG7 and horseradish
peroxidase (HRP)-conjugated donkey anti-goat IgG were from
Santa Cruz Biotechnology (Santa Cruz, CA). LC3B antibody was
obtained from Cell Signaling (Danvers, MA). Bio-Rad protein
assay reagent, Criterion XT Precast Gel, HRP-conjugated goat
anti-rabbit and anti-mouse IgG, p62 and Precision Plus Protein
Kaleidoscope Standards were obtained from Bio-Rad (Hercules,
CA). HIV protease inhibitors, amprenavir (APV), indinavir (IDV),
atazanavir (AZV), ritonavir (RTV), lopinavir (LPV), nelfinavir
(NEV), saquinavir (SQV), darunavir (DAV), and tipranavir
(TRV), were obtained through the AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH. Thapsigargin
Figure 1. Effect of HIV PIs on the UPR activation in mouse pre-
adipocytes. Representative immunoblots against CHOP, ATF-4, and
lamin B from the nuclear extracts of mouse 3T3L1 cells treated with
different concentrations of HIV PIs for 6 h are shown. A). lopinavir (LPV).
B). lopinavir/ritonavir (LPV/RTV= 4:1). The density of immunoblot was
determined by Image J. Relative protein levels of CHOP and ATF-4 were
normalized using Lamin B as a loading control.
doi:10.1371/journal.pone.0059514.g001
Figure 2. Effect of HIV PIs on UPR activation in differentiated
mouse adipocytes. Differentiated 3T3-L1 cells were treated with
different concentrations of LPV, or LPV/RTV for 6 h. Total cellular RNA
was isolated. The mRNA levels of CHOP and ATF-4 were quantified by
real-time RT-PCR and normalized using internal control b-actin. Values
are mean 6 SE of three independent experiments. Statistical
significance relative to vehicle control, *p,0.05, and **p,0.01.
doi:10.1371/journal.pone.0059514.g002
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(TG), dimethyl sulfoxide molecular biology grade (DMSO), 3-
Isobutyl-1-methylxanthine (IBMX), rosiglitazone, phosphatase
inhibitor mix, dexamethasone, hydrocortisone, Nile red, and Oil
Red O were obtained from Sigma Aldrich (St. Louis, MO).
Chemiluminescence Reagent was from PerkinElmer Life Sciences.
RNeasy MinElute Cleanup Kit was from Qiagen.
Culture of Adipocytes
3T3-L1 murine pre-adipocytes were obtained from ATCC
(Manassas, VA). Cells were maintained in DMEM with 10%
newborn calf serum and 1% penicillin-streptomycin (P-S) at 37uC
with 5% CO2 until confluence. Differentiation was induced by
replacing media with DMEM 10% fetal bovine serum (FBS), 1%
P-S, 0.5 mM IBMX, 0.8 mM insulin, and 1 mM dexamethasone.
After three days, the induction medium was removed and replaced
by DMEM 10% FBS, 1% P-S, and 0.8 mM insulin for two days,
followed by DMEM 10% FBS/1% P-S for 3–4 more days. Mature
adipocytes were used in experiments after 80% of cells visually
appeared differentiated (minimum of 8 total days).
Human Simpson-Golbai-Behmel Syndrome (SGBS) pre-adipo-
cytes were a kind gift from Dr. Martin Wabitsch (University of
Ulm, Germany) [29]. SGBS cells were maintained in DMEM/F12
with 10% FCS/1% P-S, 33 mM biotin, and 17 mM pantothenate.
Cells were induced to differentiate at confluence in serum free
DMEM/F12 with 0.01 mg/mL transferrin, 2610
ˆ28 M insulin,
161027 M cortisol, and 0.2 nM T3. For the first 3 days, this
media was also supplemented with 25 nM dexamethasone,
500 mM IBMX, and 2 mM rosiglitazone, then these three
components were not used for the rest of differentiation. Cells
were used in experiments after 80% of cells visually appeared
differentiated (average 2 weeks).
Western Blot Analysis
Total cell lysate (LC3 and p62) or nuclear proteins (UPR
activation) were prepared and used for Western blot analysis as
previously described [3,30]. Membranes were incubated with
primary antibodies in 2.5% milk-TBS for CHOP, XBP-1, ATF-4,
lamin B, p62 or b-Actin, and in 5% BSA-TBST for LC3.
Immunoreactive bands were detected using horseradish peroxi-
dase-conjugated secondary antibody and chemiluminescence. The
density of the immunoblot was analyzed using either Image J or
Quantity One (Biorad).
RNA Isolation and Quantitative Real-time RT-PCR
Total cellular RNA was isolated from 3T3-L1 pre-adipocytes
and mature adipocytes after treatment using QIAGEN RNeasy
MinElute Kit. Total RNA (2 mg) was used for first-strand cDNA
synthesis using a High-Capacity cDNA Reverse Transcription Kit
(Applied Biosytems). The mRNA levels of CHOP and ATF-4 were
quantified using the following primers: CHOP forward primer:
59GTCCCTGCCTTTCACCTTGG39; CHOP reverse primer:
59GGTTTTTGATTCTTCCTCTTCG 39; ATF-4 forward
primer: 59C CTAGGTCTCTTA GATGACTATCTGGAAG39,
ATF-4 reverse primer: 59CCAGGTCATCCATTCGAAAC
AGAGCATCG39; b-actin forward primer: 59 ACCACACCTTC-
TACAATGAG 39; b-actin reverse primer: 59 ACGACCA
GAGGCATACAG 39. iQTM SYBR Green Supermix (Bio-Rad)
was used as a fluorescent dye to detect the presence of double-
stranded DNA. The mRNA levels of target genes were normalized
using b-actin mRNA as an internal control. The ratio of
normalized mean value for each treatment group to vehicle
control (DMSO) was calculated.
Analysis of Apoptosis by Annexin V and Propidium
Iodine Staining
Cells were treated with individual HIV PIs for 24 h and stained
with Annexin V-FITC and propidium iodide using BD ApoAlert
Annexin V kit according to the protocol recommended by the
manufacturer. Stained cells were further analyzed by two-color
flow cytometry. Annexin V-FITC and propidium iodide emissions
were detected in the FL1 and FL3 channels respectively of
a Cytomics FC 500 flow cytometer (Beckman Coulter, Fullerton,
CA). At least 20,000 cells were analyzed in each treatment group.
Figure 3. Effect of HIV PIs on UPR activation in differentiated
mouse adipocytes. A) Representative immunoblots against CHOP,
ATF-4 and Lamin B from nuclear extracts of mouse differentiated 3T3L1
cells treated with different concentrations of LPV and LPR/RTV for 6 h
are shown. B–C) The density of immunoblot was determined by Image
J. Relative protein levels of CHOP and ATF-4 were normalized using
Lamin B as a loading control. Values are mean6 SE of four independent
experiments. Statistical significance relative to vehicle control, *p,0.05.
doi:10.1371/journal.pone.0059514.g003
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Assay of ER Calcium Pools
Non-differentiated 3T3-L1 cells were grown on 22630-mm
coverslips and treated with individual HIV PIs for 24 h. ER
calcium stores were analyzed using Fura-2 AM as previously
described [3]. Fluorescence images (510-nm emission after
alternate 340- and 380-nm excitation) were collected at 15-ms
intervals before and after addition of TG. The 340:380 ratios of 20
individual cells in these images were analyzed using TILLvisION
version 3.1 imaging software [3].
Figure 4. Effect of HIV PIs on the UPR activation in differentiated human adipocytes. A–B). Relative mRNA levels of CHOP and ATF-4 from
differentiated human SGBS cells treated with different concentrations of LPV or LPV/RTV for 6 h and analyzed by real-time RT-PCR. b-Actin was used
as an internal control. Values are mean6 SE of three independent experiments. Statistical significance relative to vehicle control, *p,0.05, **p,0.01.
C). Representative immunoblots against CHOP, ATF-4 and Lamin B from nuclear extracts of differentiated human SGBS cells treated with different
concentrations of LPV or LPV/RTV for 6 h are shown. The density of immunoblot was determined by Image J. Relative protein levels of CHOP and
ATF-4 were normalized using Lamin B as a loading control.
doi:10.1371/journal.pone.0059514.g004
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Nile Red and Oil Red O Staining of Intracellular Lipid
3T3-L1 cells were plated on 22622-mm glass coverslips in 6-
well plates until confluence. Cells were treated with HIV PIs while
concurrently being induced to differentiate. After 8 days, cells were
fixed with 3.7% formaldehyde in PBS for 30 min followed by two
washes with PBS. The cells were stained with 0.2% Oil Red O in
60% 2-propanol for 15 min or Nile red (100 ng/ml) for 10 min
and washed three times with PBS as previously described [31,32].
The images of Oil Red O staining were taken with a microscope
(Olympus, Tokyo, Japan) equipped with an image recorder under
a 406 lens. Images of Nile red staining were obtained under a 40
6 objective using an FITC filter on a fluorescent microscope
(Olympus, Center Valley, PA).
Quantitative Analysis of Lipid Droplets
3T3-L1 cells were plated on 22622-mm glass coverslips in 6
well plates until confluence. Cells were treated with HIV PIs while
concurrently being induced to differentiate. After 14 days, cells
were fixed with 3.7% formaldehyde in PBS for 30 min followed by
two washes with PBS. The coverslips were mounted on glass slides
and images of cells were obtained using a 40 6 objective of an
upright light microscope Motic BA200. Images were processed
using a previously published custom-made MATLAB (Math-
Works) code [33]. The lipid droplet number, areas, and % area
occupied by lipid droplet were then determined.
Isolation of Primary Mouse Adipocytes
Both wild type and CHOP2/2 mice with C57BL/6J back-
ground (8–10 weeks old) were used to obtain primary adipose cells.
After euthanization, the gonadal fat pad was excised from mice
and placed in 37uC Krebs-Ringer-Hepes (KRH) buffer (1 mM
CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 130 mM NaCl,
1.4 mM KCl, 2 mM Pyruvic Acid, 20 mM HEPES with 4 mM
NaHCO3,) with 0.83% BSA. Tissue was minced until all
fragments were no bigger than 1 mm and placed in 1 mg/mL
Type I collagenase (Worthington Biochemical) in KRH, and
digested for 30 minutes in a rotating water incubator at 37uC.
Suspension was filtered, and washed in fresh KRH to remove
bound collagenase. Solution was centrifuged at 1006g for 5
minutes and cell pellet was resuspended in DMEM containing
10% FBS, 1% P-S, 33 mM Biotin, 100 mM ascorbic acid, 4 nM
insulin and 8.3 mM L-glutamine and plated on 6-well plates. After
confluence, cells were induced to differentiate by adding 1 mg/mL
insulin, 1 mM dexamethasone, 0.5 mM IBMX, and 1 mM
rosiglitazone to media for 48 h. After two days, media was
supplemented with insulin and rosiglitazone alone. Cells were
thereafter cultured with base media for 6–8 more days for full
differentiation to occur.
Transmission Electron Microscopy (TEM)
3T3-L1 cells were plated on Permanox Quantity dishes
(Nalgene Nunc International, Rochester NY), and treated with
HIV PIs for 24 and 48 h. Cells were rinsed with PBS and fixed
with 2% glutaraldehyde for 1 hour, rinsed in 0.1M cacodylate
buffer, and fixed for another hour with 1% osmium tetroxide in
0.1M cacodylate buffer. Samples were further washed, dehydrated
in gradient ethanol and infiltrated with a 50/50 mixture of 100%
ethanol/PolyBed 812 resin for overnight, and further infiltrated
with pure PolyBed. Samples were embedded using fresh PolyBed
812 and polymerized in a 60uC oven for two days. Samples were
sectioned with a Leica EM UC6i Ultramicrotome (Leica
Microsystems) and stained with 5% uranyl acetate and Reynold’s
Lead Citrate, followed by scoping using a JEOL JEM-1230 TEM
(JEOL USA) with a Gatan Ultrascan 4000 digital camera (Gatan
Inc, Pleasanton CA). Morphometry was based on previously
published literature [34]. Electron microscope primary images
were obtained at 1000 to 12,000 6. For each treatment,
magnification 4,0006 was obtained 4 times in 15 different cells.
The cytoplasmic volume fraction of autophagosomes was obtained
by point counting with 1.5 cm spacing, and using the equation of
points falling on autophagosomes divided by points falling on
cytoplasm.
Monitoring the Autophagy Formation Using GFP-LC3
GFP-LC3 under SV promoter in the retroviral vector pBABE
was purchased from AddGene. Retroviral particles were con-
structed in 293-FT cells by cotransfection with 1 mg pBABE-puro-
GFP-LC3, 0.1 mg pCMV-VSV-G, and 0.9 mg pMDLg/pREE
using CaCl2 and HEPES mixture. Retroviral particles were
harvested from culture supernatants 72 h after transfection and
further concentrated with 8.5% PEG 6000 containing 0.4 M
NaCl. 3T3-L1 cells were infected with retrovirus in the presence of
8 mg/mL of polybrene for 48 h. Successfully infected cells were
selected with puromycin (5 mg/ml).
Analysis of Long-lived Protein Degradation
3T3L1 cells were plated on 12-well plates for overnight. The cell
media was removed and replaced by 1 mL DMEM containing
14C-Valine (0.2 Ci/ml) adjusted to 62.4 mM final concentration
using unlabeled valine and incubated at 37uC for overnight. After
removing the labeling medium, the cells were washed with 1 mL
of DMEM containing 62.4 mM valine, and then incubated with
DMEM containing 10 mM valine for 2 hours to chase out short-
lived protein. Cells were treated with HIV PIs with or without
autophagy inhibitor, 3-methyladenine (10 mM) for 24 h. At the
end of treatment, the radioactivity of the culture media and total
cellular lysate was determined as described previously [35].
Statistical Analysis
All of the experiments were repeated at least three times and the
results were expressed as mean6 SE. One-way ANOVA was used
to analyze the differences between sets of data using GraphPad
Figure 5. HIV PIs induce cell death in differentiated 3T3-L1s.
Differentiated 3T3-L1 cells were treated with different concentrations of
HIV PIs or vehicle control (DMSO) for 24 h, and then stained with
Annexin V-FITC/propidium iodide. The percentages of apoptotic and
necrotic cells were analyzed by flow cytometry. Relative amount of
apoptotic and necrotic cells compared to vehicle control (which was set
as 1) was calculated. Values are the mean 6 SE of four independent
experiments. Statistical significance relative to vehicle control, *p,0.05.
doi:10.1371/journal.pone.0059514.g005
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Figure 6. Effect of HIV PIs on adipocyte differentiation. A–B) 3T3-L1 cells were induced to differentiate while concurrently treated with
different HIV PIs (12.5 mM). After 8 days, cells were fixed and stained with Oil Red O and Nile red. Representative images of Oil Red O staining and Nile
HIV Protease Inhibitors Disrupt Lipid Metabolism
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Prism (GraphPad, San Diego, CA). A value of p,0.05 was
considered statistically significant.
Results
HIV PIs Induce ER Stress and Activate the UPR in
Adipocytes
HIV PIs, especially LPV and RTV, have been reported to
disrupt lipogenesis, induce insulin resistance, and inhibit differen-
tiation in both mouse and human adipocytes [16,20,36–39]. These
studies suggest that disruption of mitochondria function and
activation of oxidative stress contribute to HIV PI-associated
adverse effect on adipocytes. Our previous studies indicate that
activation of ER stress plays a critical role in HIV PI-induced
dysregulation of lipid metabolism in macrophages and hepatocytes
[3,40]. In order to determine whether HIV PIs have the similar
effects on the UPR activation in adipocytes as they do in other cell
types, mouse 3T3-L1 pre- and mature adipocytes were treated
with nine available HIV PIs for various time periods (1–24 h) and
the protein levels of UPR-specific genes, CHOP, ATF-4, and
XBP-1, were detected by Western Blot analysis. Similar to our
previous observations, HIV PIs differentially induced UPR
activation in pre-adipocytes and mature adipocytes. LPV, RTV,
SQV, NEV, and IDV induced significant activation of the UPR,
while APV, DAV and TRV only had modest or no activation in
adipocytes (Supplementary Figure 1 and Figure 2 in File S1). The
most significant activation of the UPR induced by LPV, RTV, and
LPV/RTV was observed between 4 to 6 h (Supplementary
Figure 3 in File S1). We therefore split these HIV PIs into two
groups: ER stress inducers and non-inducers. Interestingly, those
in the non-inducer group have much lower incidences of inducing
dyslipidemia in patients compared to those in the inducer group
[41,42].
red staining are shown. C–D) 3T3-L1 cells were induced to differentiate while concurrently treated with different HIV PIs (12.5 mM). After two weeks,
cells were fixed and 406 images were processed using MATLAB. The number and size of lipid droplets were measured. Values are mean 6 SE for
three independent experiments. Statistical significance relative to vehicle control, ***p,0.001. E) Human SGBS cells were induced to differentiate
while concurrently treated with different HIV PIs (12.5 mM) for 10 days. The intracellular lipid was stained with Oil Red O. Representative images from
three individual experiments are shown.
doi:10.1371/journal.pone.0059514.g006
Figure 7. Effect of HIV PIs on the expression of essential genes involved in lipid metabolism in differentiated 3T3-L1 cells.
Differentiated 3T3-L1 cells were treated for 6 h with increasing concentrations of LPV or LPV/RTV. Total cellular RNA was isolated and the mRNA levels
of LPL, LXRa, FABP, and SREBP-1c were quantified by real-time RT-PCR and normalized using internal control b-Actin. Values are mean 6 SE of three
independent experiments. Statistical significance relative to vehicle control, *p,0.05, and **p,0.01.
doi:10.1371/journal.pone.0059514.g007
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Based on the most current guidelines of US Department of
Health and Human Services for Use of Antiretroviral Agents in
HIV-1-infected Adults and Adolescents, HIV PIs are continuously
listed as key components of preferred HAART regimens, and will
continue to be important drugs for the foreseeable future. With the
ability to maintain viral load suppression superior to some other
PIs, LPV co-formulated with RTV (4:1) has remained a frequently
used treatment in the clinic. As LPV/RTV is also in the ER stress
inducer group and is known to induce metabolic side effects in the
clinic, we further examined the effects of LPV and LPV/RTV on
the UPR activation in pre-adipocytes and mature adipocytes. Our
studies focused on known physiological concentrations of HIV PIs
between 5–25 mM. As shown in Figure 1, LPV and LPV/RTV
dose dependently induced CHOP and ATF-4 expression in mouse
pre-adipocytes, but had no significant effect on XBP-1 expression
(data not shown). Similarly, LPV and LPV/RTV also dose-
dependently increased CHOP and ATF-4 expression at both
mRNA levels and protein levels in mature mouse adipocytes
(Figure 2 and 3). We further confirmed these findings in human
SGBS adipocytes. As shown in Figure 4, both LPV and LPV/
RTV increased CHOP and ATF-4 expression in differentiated
human adipocytes. In addition, RTV alone also significantly
activated the UPR in non-differentiated and differentiated mouse
adipocytes as well as human adipocytes (Supplementary
Figure 4 in File S1).
Figure 8. Effect of CHOP on HIV PI-induced inhibition of adipocyte differentiation. Primary murine pre-adipocytes were isolated
from wild type (WT) and CHOP2/2 mice. Cells were induced to differentiate while concurrently treated with HIV PIs (12.5 mM) for 10 days. A).
The intracellular lipid was stained with Oil Red O. Images were acquired with a 406 objective lens. Representative images for each treatment are
shown. B–C) Bright field images were acquired with a 206objective lens, and images were processed using MATLAB. The number and size of lipid
droplets were measured. Values are mean 6 SE for three independent experiments. Statistical significance relative to vehicle control, **p,0.01.
doi:10.1371/journal.pone.0059514.g008
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HIV PIs Induce Cell Death in Adipocytes
We have previously shown that HIV PI-induced ER stress is
correlated to the induction of cell apoptosis in macrophages and
hepatocytes at clinically relevant concentrations [3,40]. We further
examined whether LPV and LPV/RTV would have a similar
affect in adipocytes, which could potentially account for the
Figure 9. Effect of HIV PIs on autophagic punctate formation. 3T3-L1 cells stably expressing GFP-tagged LC3 were treated with different HIV
PIs (12.5 mM), rapamycin (RM, 30 nM), or vehicle control (DMSO) for 24 h. The fluorescence images were recorded using a A) 406, B) 636oil lens
with FITC filter. Representative images for each treatment are shown.
doi:10.1371/journal.pone.0059514.g009
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associated dysregulation of lipid metabolism. Differentiated 3T3-
L1s were treated with different concentrations of LPV, LPV/RTV
or vehicle control DMSO for 24 h. Cells were collected, stained
with annexin V-FITC and propidium iodide, and analyzed by
flow cytometry. As shown in Figure 5, LPV and LPV/RTV
promoted cell death in differentiated 3T3-L1s.
Effects of HIV PIs on Intracellular Lipid Accumulation in
Adipocytes
Previous studies have shown that HIV PIs can affect adipocyte
differentiation, but with contradictory results [23,43,44]. Our
previous studies also showed that individual HIV PIs had different
effects on lipid metabolism in macrophages and hepatocytes. APV
had little effect, but LPV and RTV had the most significant effect
on lipid metabolism [3,40]. In order to determine the effect of
APV, LPV, and LPV/RTV (4:1) on adipocytes differentiation,
Figure 10. Effect of HIV PIs on autophagosome formation in 3T3-L1 cells. Non-differentiated 3T3-L1s were treated with individual HIV PIs
(12.5 mM), rapamycin (RM, 30 nM) or vehicle control (DMSO) for 48 h. Cells were processed for transmission electron microscopy as described in
‘‘Methods’’. A–C) Representative images for each treatment at 2,0006, 4,0006or 10,0006are shown. C) The density of autophagosomes for each
treatment was point counted at 4,0006and expressed as percentage of cytoplasmic area. Statistical significance relative to vehicle control: *p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0059514.g010
Figure 11. Effect of HIV PIs on autophagy flux in 3T3L1 cells. Non-differentiated 3T3-L1 cells were treated with different concentrations of HIV
PIs for 6 h in the absence or presence of ammonium chloride (20 mM)/leupeptin (10 mM) (NH4Cl/Leu). Total cell lysates were isolated for Immunoblot
analysis of LC3-I and LC3-II. b-actin was used as loading control. NH4Cl/Leu was added to the cells 2 h prior to harvesting. Representative
immunoblots of A) LPV and B) LPV/RTV are shown. C–D). The density of immunoblot was determined by Image J. Relative a protein level of LC3-II
was normalized with b-Actin. Values are mean 6SE of three independent experiments. Statistical significance relative to vehicle control, *p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0059514.g011
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murine pre-adipocytes were induced to differentiate while
concurrently treated with 12.5 mM HIV PIs for 8 days. The
intracellular lipid was stained using Oil Red O and Nile red. As
shown in Figure 6A and B, APV had little effect on lipid
accumulation, however, LPV and LPV/RTV significantly in-
hibited lipid accumulation. Similar results were obtained with
human SGBS cells stained with Oil Red O (Figure 6E). To
increase accuracy and avoid subjectivity, we also quantitated both
the number and size of lipid droplets that accumulated in 3T3-L1s
when induced to differentiate in the presence of HIV PIs using
a MATLAB program as described previously [33]. As shown in
Figure 6C and D, LPV and LPV/RTV significantly reduced the
number of lipid droplet (LD), but had no significant effect on the
size of LD. APV had no effect on the number of LD, but increased
the size of LD. These results indicated that ER stress activators,
LPV and LPV/RTV, inhibit essential LD formation during
adipocyte differentiation.
To further determine whether HIV PI-induced inhibition of LD
formation is correlated to the inhibition of the key genes involved
in adipocyte differentiation, we determined the effect of LPV and
LPV/RTV on the mRNA expression of sterol regulatory element-
binding protein-1c (SREBP-1c), lipoprotein lipase (LPL), fatty acid
binding protein (FABP), peroxisome proliferator-activated re-
ceptor gamma (PPARc), and liver X receptor alpha (LXRa) in
differentiated 3T3L1 cells. As shown in Figure 7, LPV and LPV/
RTV significantly inhibited FABP, SREBP-1c and LPL mRNA
expression, but no effect on LXRa and PPARc (data not shown).
Effect of CHOP on HIV PI-induced Alterations of
Intracellular Lipid Accumulation in Adipocytes
To identify the potential link between the UPR activation and
alteration of intracellular lipid accumulation in adipocytes, we
isolated primary adipocytes from C57BL/6 wild type and
CHOP2/2 mice with a C57BL/6J background. Isolated primary
adipocytes were induced to differentiate while concurrently treated
with HIV PIs for 10 days. Intracellular lipid droplets were stained
with Oil Red O. As shown in Figure 8A, similar to the findings in
cultured murine and human adipocytes, LPV and LPV/RTV
significantly inhibited intracellular lipid accumulation in wild-type
mouse adipocytes. However, in the absence of CHOP, LPV and
LPV/RTV had less effect on intracellular lipid accumulation. We
further analyzed the effect of CHOP on LD formation using
MATLAB. A shown in Figure 8B and C, HIV PI-induced
inhibition of LD formation was abrogated in the absence of
CHOP. These results suggest that HIV PI-induced CHOP
expression contributes to the dysregulation of differentiation in
adipocytes.
Effect of HIV PIs on Autophagy Activation in Adipocytes
Autophagy has been recently identified as a cellular target for
dysregulation of lipid metabolism [45], and it regulates body lipid
accumulation by controlling adipocyte differentiation [27].
Autophagy activity is also closely linked to ER stress signaling
pathways [28,46]. To investigate if autophagy dysfunction is
involved in HIV PI-induced inhibition of adipocyte differentiation,
Figure 12. A) Effect of HIV PIs on p62 degradation. Differentiated 3T3-L1 cells were treated with different amounts of HIV PIs for 48 h, and total
cell lysates were used to analyze p62 protein levels. Representative immunoblots of p62 and b-actin are shown. The density of the immunoblots was
analyzed using Image J software. B) Effect of HIV PIs on long-lived protein degradation. Differentiated 3T3-L1 cells were metabolically labeled with
14C-valine, then treated with HIV PIs (12.5 mM) for 24 h. The degradation of long-lived protein was analyzed as described in ‘‘Methods’’. Results are
the mean 6 SE of three independent experiments ***p,0.001.
doi:10.1371/journal.pone.0059514.g012
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non-differentiated 3T3-L1 cells stably transfected with GFP-LC3
were treated with HIV PIs (12.5 mM) or rapamycin (RM, 30 nM)
for 24 h, the autophagic punctate dot formation was observed
under fluorescence microscopy. As shown in Figure.9, LPV and
LPV/RTV increased the number of autophagic punctate dots. We
further confirmed the effect of HIV PIs on autophagosome
accumulation using electron microscopy, a more accurate
assessment of autophagy induction. As shown in Figure 10, there
was a significant increase of autophagosome density with LPV and
LPV/RTV in 3T3-L1 cells.
Effect of HIV PIs on Autophagic Flux
The increase of autophagosome number does not always
indicate the increase of autophagic activity. Accumulation of
autophagosomes can be caused by an increase in the induction of
autophagy or an impairment of autophagolysosomal maturation.
We therefore examined the effect of HIV PIs on autophagic flux
by measuring protein levels of membrane-associated form LC3-II
in the presence of lysosome inhibitors (ammonium chloride/
Leupetin) in 3T3L1 cells. As shown in Figure 11, although LPV
and LPV/RTV increased the protein levels of LC3-II, in the
presence of lysosome inhibitors, there was no further increase of
LC3-II compared to DMSO control. Furthermore, HIV PIs had
Figure 13. Effect of HIV PIs on ER calcium stores. Non-differentiated 3T3-L1 cells were treated with HIV PIs (RTV, LPV, or LPV/RTV, 12.5 mM) or
vehicle control (DMSO) for 24 h. ER calcium stores were assessed by Fura-2 fluorescence ratio of 340:380 nm in individual cells before and after
addition of thapsigargin (TG, 100 nM). Representative tracing for a summation of at least 15 cells is shown. A) Cells were treated with RTV or LPV. B)
Cells were treated with LPV/RTV. C) Relative calcium content was calculated by total area under the curve for each treatment group and compared to
vehicle control (which was set as 1). Statistical significance relative to vehicle control, **p,0.01.
doi:10.1371/journal.pone.0059514.g013
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no effect on the expression of ATG5 and ATG7, which are two
essential proteins involved in autophagosome formation (Supple-
mentary Figure 6 in File S1). These results suggest that LPV and
LPV/RTV may inhibit the degradation of LC3-II rather than
induce autophagy activation.
To further determine the effect of HIV PIs on autophagic
degradation, we examined the effect of LPV and LPV/RTV on
the accumulation of p62. p62 is a nuclear membrane protein
proposed to be specifically degraded through the autophagic
pathway as it specifically binds to LC3-II and serves as a link to
ubiquitinated substrates [47,48]. Therefore, the activity of
autophagy should inversely correlate with p62 protein levels.
The results indicated that LPV and LPV/RTV dose-dependently
increased the accumulation of p62 in differentiated 3T3-L1
adipocytes (Figure 12A), while RM significantly decreased p62
protein level. To further follow this observation, we examined the
effect of HIV PIs on degradation of long-lived protein using 14C-
valine labeled differentiated 3T3-L1 adipocytes. As shown in
Figure 12B, LPV and LPV/RTV significantly inhibited autopha-
gic proteolysis of long-lived proteins in adipocytes. TG, a known
ER stress activator, also showed significant inhibition. Taken
together, these results suggest that the degradation of autophagic
components was inhibited by HIV protease inhibitors.
Effect of HIV PIs on ER Calcium Stores in Adipocytes
ER stress can be activated by a number of insults. Maintenance
of ER calcium homeostasis is essential for many cellular functions.
TG, a sarcoplasmic/ER calcium ATPase inhibitor, depletes the
ER calcium stores and activates the UPR in many different cells
[49,50]. We have previously shown RTV depletes ER calcium in
macrophages leading to UPR activation [3]. We further examined
the effect of LPV, RTV and LPV/RTV on ER calcium stores in
adipocytes. 3T3-L1 pre-adipocytes were treated with HIV PIs
(12.5 mM) or vehicle control (DMSO) for 24 h, and the ER
calcium content was determined using the fluorescent calcium
indicator Fura-2/AM as described previously [3]. As shown in
Figure 13, RTV-, LPV- or LPR/RTV-treated cells markedly
reduced the response to TG, indicating that ER calcium stores
were depleted. A recent study has reported that TG specifically
blocks autophagosomal-lysosomal fusion and inhibits autophagy
activity [51]. The HIV PI-induced ER calcium depletion may also
account for the observed inhibition of autophagy activity.
Discussion
Although HIV PIs are extremely effective in decreasing viral
load, HIV patients on HAART containing HIV PIs are at
increased risk for developing metabolic syndrome and cardiovas-
cular diseases [36,52]. The field of ER stress and UPR has gained
great attention during the last decade. The UPR signaling
pathway plays an important role in regulating normal functions
of various cells including hepatocytes, b-cells, and macrophages.
Consequently, dysregulation of the UPR signaling pathway has
been implicated in various human diseases such as diabetes, fatty
liver, and cardiovascular diseases [53–56].
An old paradigm of dyslipidemia considered hepatocytes and
macrophages as central players in the lipid metabolism dysregula-
tion. In parallel, investigations attempting to determine the cellular
mechanism of HIV PI-induced dyslipidemia have thoroughly
focused on these two cell types. However, increasing evidence
demonstrates that adipose tissue is a central player in metabolic
disease, including dysregulation of lipid metabolism and insulin
resistance [14,57,58].
Through the current studies, we have attempted to elucidate the
mechanistic dysregulations induced by HIV PIs in adipocytes.
Previous studies from our laboratory suggest that activation of ER
stress represents an important cellular mechanism underlying HIV
PI-induced inflammation and dyslipidemia [3,5,40]. In addition,
studies from other investigators have linked ER stress to HIV PI-
induced insulin resistance and dysfunction in adipocytes [20,36]. A
recent study by Capel, et al, showed that LPV/RTV adversely
affected differentiation, lipid content, mitochondrial function,
ROS production and insulin sensitivity in adipocytes [37].
However, little is known of how HIV PIs affect lipid metabolism
in adipocytes.
In the current study, we show that HIV PIs induce ER stress in
a time and dose-dependent manner in adipocytes, similar to what
has been shown in macrophages and hepatocytes (Figure 1–4 and
Supplementary Figure 1–4 in File S1) [3,40]. However, not all
HIV PIs activated the UPR to the same extent, which may be
explained by pharmacokinetic differences within this drug class.
HIV PIs differ in molecular weight, ionization, and lipophilicity
(oil-water partition coefficient, or log P), all of which determine
rate of transport through cellular membranes [59,60]. Interest-
ingly, these differences of log P and cellular accumulation parallel
our observations of ER stress activation i.e. high for NEV and
SQV, intermediate for IDV, RTV and LPV, and lower for DAV
[59,61–65]. While further study is needed to conclusively de-
termine the log P and intracellular concentrations for LPV and
RTV, the connection is notable and may correlate to observed
difference of dyslipidemia induction in the clinic.
In this study, we have focused on the most widely used HIV PIs,
LPV/RTV (4:1), which has been demonstrated to induce
dyslipidemia in patients [66–68], and to study the correlation of
ER stress activation and alterations in adipogenesis. LPV/RTV
has previously been shown to induce metabolic alternations in
various cells and tissues [3–5,39,69]. Our results indicated that
LPV/RTV significantly activate the UPR and inhibit adipocyte
differentiation in physiologic concentration ranges (6.25 to 25 mM)
[70]. We hypothesized that the induction of ER stress may be the
cause of these alterations, as the ER and LD organelles are so
closely intertwined [71–74]. Indeed, knockout of CHOP, a down-
stream UPR transcription factor, abrogated HIV PI-induced
dysregulation of adipogenesis. While we demonstrated this
phenomenon in primary adipocytes in this particular study, we
also have preliminary data indicating that this occurs in vivo.
It is now clear that autophagy also plays a critical role in lipid
droplet formation and metabolism [75,76]. Recent study by
Gibellini et al, reported that AZV induced both apoptosis (high
doses) and autophagy (low dose) in human cancer preadipocytes
[76]. However, the concentration of AZV used in this study was at
a non-physiological range (50–200 mM). The physiological con-
centration of AZV ranges from 10–15 mM [77]. In addition,
increase of LC3-II and GFP-LC3 punctae formation may be
caused by inhibition of autophagy flux rather than increased
activity of the pathway.
Our current study further investigated the effect of HIV PIs at
clinically relevant concentration on autophagy induction and
activity in our model. We have demonstrated that LPV, LPV/
RTV and RTV do induce autophagosome accumulation in
murine adipocytes (Figure 9, 10 and supplementary Figure 5 in
File S1). Recently, it has been reported that TG, an ER stress
inducer widely used to induce autophagy, actually inhibited
autophagy activity [51]. Our results also indicated that activation
of the UPR is correlated to HIV PI-induced inhibition of
autophagy activity and adipocyte differentiation. Previous studies
have shown that HIV PIs also inhibit the activity of the 26S
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proteasome at high concentration, with LPV and RTV inhibiting
chymotryptic activity 50–60% at 25 mM [78]. Therefore, our
findings of p62 accumulation at high concentrations of LPV and
LPV/RTV may be partially due to the inhibition of proteasome
activity in addition to the inhibition of autophagy activity. Analysis
of autophagic proteolysis of long-lived proteins further confirmed
that HIV PIs inhibited autophagy flux. However, how HIV PI-
induced ER stress and autophagy are entwined remains to be fully
examined. Recent studies done by Yu et al identified CHOP as
a regulator of macroautophagy. CHOP deficiency attenuated
spinal and bulbar muscular atrophy, a disease triggered in part
through ER stress activation via activation of macroautophagy
[79]. Our recent studies also showed that HIV PI-induced
inhibition of autophagy activity in primary mouse hepatocytes is
also reversed in the absence of CHOP (unpublished data).
Whether and how CHOP is involved in HIV PI-induced
dysregulation of autophagy activity in adipocytes remains to be
further identified and is our ongoing project.
In summary, we have shown that HIV PIs differentially activate
ER stress in adipocytes, alter differentiation, disrupt the expression
of key regulatory genes involved in lipid metabolism, and inhibit
autophagy flux. These alterations are unlikely separate phenom-
enon, but rather intertwined with the activation of ER stress via
depletion of ER calcium. Molecules that modulate ER stress
response would be potential therapeutic targets for various diseases
including HIV PI-induced dysregulation of lipid metabolism and
metabolic syndrome.
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